Literature DB >> 32194700

Long non-coding RNA LINC00152 acts as a sponge of miRNA-193b-3p to promote tongue squamous cell carcinoma progression.

Xiuhua Li1,2, Bing Rui3, Yongbing Cao2, Xiaojian Gong2, Hongjiao Li1.   

Abstract

Dysregulated expression of long non-coding RNAs has been determined to be important in cancer development; however, their role in tongue squamous cell carcinoma (TSCC) progression and carcinogenesis, to the best of our knowledge, is yet to be elucidated. The present study revealed that long intergenic non-coding RNA 00152 (LINC00152) expression was significantly increased in human TSCC tissues compared with in tissues from matched controls using RT-qPCR. In TSCC cell lines, CAL-27 and SCC-9, LINC00152 was revealed to promote TSCC cell proliferation, enhance cell cycle progression and inhibit cell apoptosis. Additionally, migration and invasion of TSCC cell lines was increased in response to LINC00152 overexpression. Mechanistically, LINC00152 was determined to be localized in the cytoplasm and acted as a microRNA (miR)-193b-3p sponge, and LINC00152 knockdown or miR-193b-3p mimics both inhibited PI3K signaling pathway activation and downstream AKT phosphorylation; therefore, promoting TSCC progression in vitro. Overall, the results of the present study suggested that increased LINC00152 expression in TSCC tissues may act as a sponge of miR-193b-3p to promote cancer progression in vitro.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  LINC00152; PI3K; long non-coding RNA; microRNA-193b-3p; tongue squamous cell carcinoma

Year:  2020        PMID: 32194700      PMCID: PMC7039063          DOI: 10.3892/ol.2020.11293

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  41 in total

1.  Long intergenic non-coding RNA 00152 promotes renal cell carcinoma progression by epigenetically suppressing P16 and negatively regulates miR-205.

Authors:  Yongjun Wang; Jianzhen Liu; Hongzhong Bai; Yi Dang; Pei Lv; Shucai Wu
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

2.  Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age.

Authors:  Marilena Vered; Dan Dayan; Alex Dobriyan; Ran Yahalom; Bruria Shalmon; Iris Barshack; Lev Bedrin; Yoav P Talmi; Shlomo Taicher
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-07       Impact factor: 4.553

3.  miR-193b-3p possesses anti-tumor activity in ovarian carcinoma cells by targeting p21-activated kinase 3.

Authors:  Jinzhi Zhang; Jinjin Qin; Yuanyuan Su
Journal:  Biomed Pharmacother       Date:  2017-11-21       Impact factor: 6.529

Review 4.  Long non-coding RNA HOTAIR: A novel oncogene (Review).

Authors:  Xin Yu; Zheng Li
Journal:  Mol Med Rep       Date:  2015-07-31       Impact factor: 2.952

5.  Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression.

Authors:  Yanmei Han; Qiuyan Liu; Jin Hou; Yan Gu; Yi Zhang; Zhubo Chen; Jia Fan; Weiping Zhou; Shuangjian Qiu; Yonghong Zhang; Tao Dong; Ning Li; Zhengping Jiang; Ha Zhu; Qian Zhang; Yuanwu Ma; Lianfeng Zhang; Qingqing Wang; Yizhi Yu; Nan Li; Xuetao Cao
Journal:  Cell       Date:  2018-03-29       Impact factor: 41.582

Review 6.  Long noncoding RNA in prostate, bladder, and kidney cancer.

Authors:  Elena S Martens-Uzunova; René Böttcher; Carlo M Croce; Guido Jenster; Tapio Visakorpi; George A Calin
Journal:  Eur Urol       Date:  2013-12-14       Impact factor: 20.096

Review 7.  MALAT1-mediated tumorigenesis.

Authors:  Jianghua Liu; Wan-Xin Peng; Yin-Yuan Mo; Dianzhong Luo
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

8.  Long noncoding RNA associated-competing endogenous RNAs in gastric cancer.

Authors:  Tian Xia; Qi Liao; Xiaoming Jiang; Yongfu Shao; Bingxiu Xiao; Yang Xi; Junming Guo
Journal:  Sci Rep       Date:  2014-08-15       Impact factor: 4.379

9.  Analysis of the outcome of young age tongue squamous cell carcinoma.

Authors:  Jae-Ho Jeon; Min Gyun Kim; Joo Yong Park; Jong Ho Lee; Myung Jin Kim; Hoon Myoung; Sung Weon Choi
Journal:  Maxillofac Plast Reconstr Surg       Date:  2017-12-25

10.  Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing.

Authors:  Fan Wang; Juan Lu; Xiaohong Peng; Jie Wang; Xiong Liu; Xiaomei Chen; Yiqi Jiang; Xiangping Li; Bao Zhang
Journal:  J Exp Clin Cancer Res       Date:  2016-01-22
View more
  5 in total

1.  LINC00152 Drives a Competing Endogenous RNA Network in Human Hepatocellular Carcinoma.

Authors:  Rossella Pellegrino; Mirco Castoldi; Fabio Ticconi; Britta Skawran; Jan Budczies; Fabian Rose; Constantin Schwab; Kai Breuhahn; Ulf P Neumann; Nadine T Gaisa; Sven H Loosen; Tom Luedde; Ivan G Costa; Thomas Longerich
Journal:  Cells       Date:  2022-05-03       Impact factor: 7.666

2.  MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway.

Authors:  Shu Yang; Guangyan Yang; Han Wu; Lin Kang; Jiaqing Xiang; Peilin Zheng; Shanhu Qiu; Zhen Liang; Yan Lu; Lijing Jia
Journal:  Diabetologia       Date:  2021-12-16       Impact factor: 10.122

3.  Integrative Analysis of RNA Expression and Regulatory Networks in Mice Liver Infected by Echinococcus multilocularis.

Authors:  Tingli Liu; Hong Li; Yanping Li; Liqun Wang; Guoliang Chen; Guiting Pu; Xiaola Guo; William C Cho; Majid Fasihi Harandi; Yadong Zheng; Xuenong Luo
Journal:  Front Cell Dev Biol       Date:  2022-03-24

4.  Identification of differentially expressed microRNAs as potential biomarkers for carcinoma ex pleomorphic adenoma.

Authors:  Hyojin Kim; Shin Eun; Woo-Jin Jeong; Soon-Hyun Ahn; Yun Jung Bae; Joong Seob Lee; Heejin Kim
Journal:  Sci Rep       Date:  2022-08-04       Impact factor: 4.996

Review 5.  Long non-coding RNA LINC00152 in cancer: Roles, mechanisms, and chemotherapy and radiotherapy resistance.

Authors:  Shuang Li; Weiping Yao; Ruiqi Liu; Liang Gao; Yanwei Lu; Haibo Zhang; Xiaodong Liang
Journal:  Front Oncol       Date:  2022-08-10       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.